Biopeak, a pioneer in the Indian longevity and health optimization space, has raised $2.7 million (approx. ₹22.5 crore) in a follow-on funding round. The investment was led by NKSquared, the investment vehicle of Zerodha co-founder Nikhil Kamath.
This marks Kamath’s second major bet on the startup, following a $1.43 million infusion in August 2024. The fresh capital will be used to scale Biopeak’s “Family Health Office” model, enhance its proprietary AI diagnostics, and launch a second flagship clinic in Bengaluru.
Redefining Healthspan: The “Family Health Office”
Founded in 2025 by Rishi Pardal (former United Breweries CEO) and Shiva Subramanian, Biopeak is moving away from the “episodic” nature of traditional healthcare. Instead, it offers a high-touch, data-heavy approach to longevity—optimizing the number of years a person lives in peak physical and cognitive health.
The platform targets high achievers, executives, and women navigating health transitions, offering a level of concierge medical management typically reserved for ultra-high-net-worth individuals.
The Biopeak Diagnostic Arsenal:
-
Molecular Profiling: Organic acid profiling and microbiome mapping.
-
Genomics: Whole-exome functional genomics tailored to Indian disease patterns.
-
Hormonal Rhythms: Salivary cortisol tracking to manage stress and burnout.
-
Deep Imaging: Integrated MRI, CT, DXA, and ECHO scans for early risk detection.
[Image: A modern Biopeak longevity clinic interior featuring advanced diagnostic suites and a data-driven “war room” for health managers]
Scaling “India-First” Longevity Science
While longevity science is a booming trend in the West, Biopeak distinguishes itself by focusing on Indian biology. The startup’s AI tools analyze data from wearables and diagnostics to create interventions for nutrition, sleep, and recovery that account for the specific metabolic risks common in the Indian population.
“What’s been missing is a clinical system that connects diagnostics, specialists, and follow-up into one long-term view of health,” said Rishi Pardal, Co-founder & CEO. “The validation of our model over the past year has given investors the confidence to scale our physical and digital infrastructure.”
Market Traction and Growth
-
Expansion: Following the success of its first Bengaluru clinic, a second flagship center is slated to open next month.
-
Partnerships: Biopeak is collaborating with the Indian Institute of Science (IISc) and a global board of advisors to refine its longevity protocols.
-
Investor Pedigree: In addition to Nikhil Kamath, the company is backed by Accel and Claypond Capital (Ranjan Pai’s family office).
By: Vanshika Tayal
